Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

Autoři	FORNEROD M. MA J. NOORT S. LIU Y. WALSH M. P. SHI L. NANCE S. LIU Y. L. WANG Y. Y. SONG G. C. LAMPRECHT T. EASTON J. MULDER H. L. YERGEAU D. MYERS J. KAMENS J. L. OBENG E. A. PIGAZZI M. JAROŠOVÁ Marie KELAIDI C. POLYCHRONOPOULOU S. LAMBA J. K. BAKER S. D. RUBNITZ J. E. REINHARDT D. VAN DEN HEUVEL-EIBRINK M. M. LOCATELLI F. HASLE H. KLCO J. M. DOWNING J. R. ZHANG J. H. POUNDS S. ZWAAN C. M. GRUBER T. A.
Rok publikování	2021
Druh	Článek v odborném periodiku
Časopis / Zdroj	BLOOD CANCER DISCOVERY
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
www	https://bloodcancerdiscov.aacrjournals.org/content/2/6/586
Doi	http://dx.doi.org/10.1158/2643-3230.BCD-21-0049
Klíčová slova	Pediatric Myeloid-Related Acute Leukemias; Prognostic Indicators; Integrative Genomic Analysis
Popis	Genomic characterization of pediatric patients with acute myeloid leukemia (AML) has led to the discovery of somatic mutations with prognostic implications. Although gene-expression profiling can differentiate subsets of pediatric AML, its clinical utility in risk stratification remains limited. Here, we evaluate gene expression, pathogenic somatic mutations, and outcome in a cohort of 435 pediatric patients with a spectrum of pediatric myeloid-related acute leukemias for biological subtype discovery. This analysis revealed 63 patients with varying immunophenotypes that span a T-lineage and myeloid continuum designated as acute myeloid/T-lymphoblastic leukemia (AMTL). Within AMTL, two patient subgroups distinguished by FLT3-ITD and PRC2 mutations have different outcomes, demonstrating the impact of mutational composition on survival. Across the cohort, variability in outcomes of patients within isomutational subsets is influenced by transcriptional identity and the presence of a stem cell-like gene-expression signature. Integration of gene expression and somatic mutations leads to improved risk stratification. SIGNIFICANCE: Immunophenotype and somatic mutations play a significant role in treatment approach and risk stratification of acute leukemia. We conducted an integrated genomic analysis of pediatric myeloid malignancies and found that a combination of genetic and transcriptional readouts was superior to immunophenotype and genomic mutations in identifying biological subtypes and predicting outcomes.